Who owns ZENTALIS PHARMACEUTICALS INC COM?
- Ticker: ZNTL
- CUSIP Number: 98943l107
Tip: Access positions for across all investors
Analyze quarterly positions in Zentalis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Zentalis Pharmaceuticals stock
Who bought or sold ZENTALIS PHARMACEUTICALS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Squadron Capital Management | 4.0M | $9.4M | 100% | Mar 2026 |
|
| 5AM Venture Management | 3.9M | $9.2M | 0% | Mar 2026 |
|
| Two Sigma Investments | 3.0M | $6.9M | 101% | Mar 2026 |
|
| Acadian Asset Management | 2.8M | $6.7M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 2.3M | $5.4M | 100% | Mar 2026 |
|
| Renaissance Technologies | 1.9M | $4.5M | -33% | Mar 2026 |
|
| Citadel Advisors | 1.8M | $4.1M | -11% | Mar 2026 |
|
| D. E. Shaw & Co | 1.5M | $3.5M | -11% | Mar 2026 |
|
| Opaleye Management | 1.4M | $3.3M | 1% | Mar 2026 |
|
| Decheng Capital | 1.3M | $3.1M | 0% | Mar 2026 |
|
| Millennium Management | 1.3M | $3.0M | 92% | Mar 2026 |
|
| BlackRock | 1.3M | $3.0M | 2% | Mar 2026 |
|
| Bank of America Corporation | 1.1M | $2.6M | 100% | Mar 2026 |
|
| PRIMECAP Management Company | 957k | $2.2M | 0% | Mar 2026 |
|
| Pfizer | 954k | $2.0M | 0% | Mar 2026 |
|
| Connor, Clark & Lunn Investment Management | 792k | $1.9M | 1% | Mar 2026 |
|
| Qube Research & Technologies | 637k | $1.5M | 3547% | Mar 2026 |
|
| Geode Capital Management | 621k | $1.5M | 5% | Mar 2026 |
|
| GSA Capital Partners | 620k | $1.5M | -47% | Mar 2026 |
|
| Susquehanna International | 617k | $1.4M | 5861% | Mar 2026 |
|
| Almitas Capital | 610k | $1.4M | 0% | Mar 2026 |
|
| Barclays | 591k | $1.4M | 4% | Mar 2026 |
|
| Jane Street | 490k | $1.1M | 4% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 471k | $1.1M | 12% | Mar 2026 |
|
| Goldman Sachs Group | 463k | $1.1M | 291% | Mar 2026 |
|
| Marshall Wace | 393k | $919k | 58% | Mar 2026 |
|
| Peapod Lane Capital | 367k | $835k | -18% | Mar 2026 |
|
| Vanguard Portfolio Management | 361k | $844k | 100% | Mar 2026 |
|
| Morgan Stanley | 350k | $820k | -56% | Mar 2026 |
|
| XTX Topco | 323k | $755k | -44% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 305k | $713k | 100% | Mar 2026 |
|
| Creative Planning | 285k | $667k | 10% | Mar 2026 |
|
| FMR | 284k | $664k | 17% | Mar 2026 |
|
| CDC Financial | 284k | $664k | 100% | Mar 2026 |
|
| Anfield Capital Management | 275k | $642k | 13% | Mar 2026 |
|
| Dimensional Fund Advisors | 272k | $637k | 183% | Mar 2026 |
|
| Stonepine Capital Management | 269k | $630k | -42% | Mar 2026 |
|
| Woodline Partners | 266k | $623k | -50% | Mar 2026 |
|
| State Street Corporation | 250k | $584k | -8% | Mar 2026 |
|
| Sei Investments | 192k | $448k | 15% | Mar 2026 |
|
| UBS Group | 156k | $364k | -77% | Mar 2026 |
|
| Quarry | 150k | $351k | 14% | Mar 2026 |
|
| ADAR1 Capital Management | 145k | $338k | 81% | Mar 2026 |
|
| PanAgora Asset Management | 140k | $327k | 61% | Mar 2026 |
|
| Invesco | 126k | $294k | -33% | Mar 2026 |
|
| Northern Trust | 118k | $277k | 27% | Mar 2026 |
|
| Hudson Bay Capital Management | 117k | $274k | 100% | Mar 2026 |
|
| E.S. Barr & Company | 110k | $257k | 91% | Mar 2026 |
|
| Seven Fleet Capital Management | 110k | $257k | 100% | Mar 2026 |
|
| Simplex Trading | 99k | $231k | 100% | Mar 2026 |
|
| Point72 Asset Management | 95k | $222k | -5% | Mar 2026 |
|
| Graham Capital Management | 92k | $216k | 2% | Mar 2026 |
|
| Bridgeway Capital Management | 77k | $181k | 0% | Mar 2026 |
|
| Citigroup | 77k | $181k | 100% | Mar 2026 |
|
| 49 Wealth Management | 66k | $155k | -6% | Mar 2026 |
|
| Federated Investors | 66k | $153k | 90% | Mar 2026 |
|
| Commonwealth Equity Services | 61k | $144k | 0% | Mar 2026 |
|
| Hrt Financial | 52k | $122k | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 51k | $120k | 100% | Mar 2026 |
|
| Rbf Capital | 50k | $117k | -38% | Mar 2026 |
|
| American Century Companies | 49k | $114k | 277% | Mar 2026 |
|
| OMERS Administration Corporation | 48k | $112k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 47k | $110k | 100% | Mar 2026 |
|
| Tudor Investment Corporation | 35k | $82k | 0% | Mar 2026 |
|
| Quadrature Capital | 33k | $78k | -76% | Mar 2026 |
|
| Private Advisor | 32k | $74k | 100% | Mar 2026 |
|
| Squarepoint Ops | 31k | $72k | -72% | Mar 2026 |
|
| Headlands Technologies | 30k | $70k | 100% | Mar 2026 |
|
| Regency Capital Management | 30k | $69k | 0% | Mar 2026 |
|
| Marquette Asset Management | 29k | $141k | 100% | Jun 2026 |
|
| State of Wyoming | 29k | $67k | 100% | Mar 2026 |
|
| Carson Advisory | 23k | $55k | -1% | Mar 2026 |
|
| Raymond James Financial | 23k | $54k | 15% | Mar 2026 |
|
| AQR Capital Management | 23k | $53k | -51% | Mar 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 22k | $53k | -56% | Mar 2026 |
|
| Vanguard Global Advisers | 22k | $51k | 100% | Mar 2026 |
|
| Prudential Financial | 21k | $49k | -15% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 21k | $48k | 100% | Mar 2026 |
|
| Springbok Capital Management | 20k | $48k | 100% | Mar 2026 |
|
| Sivia Capital Partners | 20k | $47k | 0% | Mar 2026 |
|
| Birchview Capital | 18k | $41k | 3% | Mar 2026 |
|
| Evergreen Capital Management | 17k | $40k | 0% | Mar 2026 |
|
| Catalyst Funds Management Pty | 17k | $39k | 100% | Mar 2026 |
|
| CTC Alternative Strategies | 13k | $29k | 100% | Mar 2026 |
|
| Shay Capital | 11k | $25k | 100% | Mar 2026 |
|
| Cornerstone Wealth Management | 10k | $24k | 100% | Mar 2026 |
|
| CWM | 5.4k | $13k | -37% | Mar 2026 |
|
| EverSource Wealth Advisors | 1.7k | $4.0k | 3% | Mar 2026 |
|
| Group One Trading | 1.5k | $3.4k | 100% | Mar 2026 |
|
| Tower Research Capital | 1.1k | $2.7k | 100% | Mar 2026 |
|
| Bryn Mawr Trust | 1.0k | $2.3k | 0% | Mar 2026 |
|
| NISA Investment Advisors | 387.00 | $906.005700 | 0% | Mar 2026 |
|
| Fortitude Family Office | 209.00 | $488.997300 | 100% | Mar 2026 |
|
| HighMark Wealth Management | 130.00 | $304.005000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 98.00 | $0 | 100% | Mar 2026 |
|
| Silicon Valley Capital Partners | 84.00 | $196.996800 | 100% | Mar 2026 |
|
| Optiver Holding B.V. | 44.00 | $102.999600 | 0% | Mar 2026 |
|
| SBI Securities | 27.00 | $62.999100 | 0% | Mar 2026 |
|
| CWM Advisors | 21.00 | $50.001000 | 31% | Mar 2026 |
|
| Wells Fargo & Company | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Zentalis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 1.5M | $2.0M |
| Wealth Enhancement Advisory Services | Dec 2025 | 130k | $232k |
| Jacobs Levy Equity Management | Dec 2025 | 125k | $168k |
| Walleye Trading Advisors | Dec 2025 | 110k | $149k |
| Algert Coldiron Investors | Dec 2025 | 49k | $65k |
| Acorn Wealth Advisors | Dec 2025 | 20k | $27k |
| Ieq Capital | Dec 2025 | 12k | $17k |
| None | Dec 2025 | 11k | $14k |
| Highline Wealth Partners | Dec 2025 | 5.0k | $6.8k |
| Covestor | Dec 2025 | 51.00 | $0 |
| Caitong International Asset Management | Dec 2025 | 1.00 | $1.000000 |